Sophie Ramel
Roscoff, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial.
Journal: Diabetes research and clinical practice
Published: August 05, 2026
Feasibility and Tolerance of High-Intensity Interval Training in Adults With Cystic Fibrosis.
Journal: Archives of rehabilitation research and clinical translation
Published: June 22, 2026
How are patients experiencing the therapeutic paradigm shift in cystic fibrosis?
Journal: La Revue du praticien
Published: January 23, 2026
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.
Journal: Frontiers in pharmacology
Published: July 07, 2025
Study of Insulin Treatment Modalities in Adults With Cystic Fibrosis-Related Diabetes After Elexacaftor-Tezacaftor-Ivacaftor Therapy.
Journal: Clinical therapeutics
Published: June 02, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.
Journal: The Lancet. Respiratory medicine
Published: March 27, 2025
Elexacaftor/Tezacaftor/Ivacaftor Population Pharmacokinetics in Pediatric Patients With Cystic Fibrosis.
Journal: Clinical and translational science
Published: March 07, 2025
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis.
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 02, 2024
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Journal: The Lancet. Respiratory medicine
Published: April 11, 2024
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Journal: Annals of the American Thoracic Society
Published: April 05, 2024
Last Updated: 09/26/2026